To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min New agreement will put the Alamo ...
First Wave BioPharma Inc (NASDAQ:FWBI) announced an agreement with Sanofi SA (NASDAQ:SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results